Seventeen million people die of transmittable diseases and 2/3 of the world's population
suffer them annually. Malaria, tuberculosis, AIDS, hepatitis, and reemerging and new …

Membrane fusion events allow enveloped viruses to enter and infect cells. The study of
these processes has led to the identification of a number of proteins that mediate this …

Dedicated to the memory of Professors Henry G. Kunkel and Bruce Merrifield (Rockefeller
University, New York), who introduced us to the fascinating worlds of immunology and …

Human antibodies elicited in response to hepatitis C virus (HCV) infection are anticipated to
react with the native conformation of the viral envelope structure. Isolation of these …

Hepatitis C virus-like particles (HCV-LPs) containing the structural proteins of HCV H77
strain (1a genotype) was used as a model for HCV virion to study virus-cell interaction. HCV …

The prevalence of Hepatitis C virus (HCV) is approximately 3% around the world. This virus
causes chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. The effectiveness of …

Background: Infection with the hepatitis C virus (HCV) causes acute hepatitis. This disease
has a high probability of becoming chronic and leading to cirrhosis, but a more deadly …

Epstein-Barr virus (EBV) invasion of B-lymphocytes involves EBV gp350/220 binding to B-
lymphocyte CR2. The anti-gp350 monoclonal antibody (mAb)-72A1 Fab inhibits this binding …

Virulence and immunity are still poorly understood in Mycobacterium tuberculosis. The
H37Rv M. tuberculosis laboratory strain genome has been completely sequenced, and this …

Receptor–ligand interactions between synthetic peptides and normal human erythrocytes
were studied to determine Plasmodium falciparum merozoite surface protein‐3 (MSP‐3) …